|
| 36129377 | Implementation of the web-based calculator estimating odds ratio of severe COVID-19 for unvaccinated individuals in a country with high coronavirus-related death toll. | Allergy | 2023 |
| 37587886 | BCOR expression in paediatric pineoblastoma. | Folia Neuropathol | 2023 |
| 37612452 | Identification and subsequent validation of transcriptomic signature associated with metabolic status in endometrial cancer. | Sci Rep | 2023 |
| 37546401 | Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients. | Front Oncol | 2023 |
| 37935712 | Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer. | Sci Rep | 2023 |
| 37452347 | Pharmacovariome scanning using whole pharmacogene resequencing coupled with deep computational analysis and machine learning for clinical pharmacogenomics. | Hum Genomics | 2023 |
| 35340328 | miRNAs as Predictive Factors in Early Diagnosis of Gestational Diabetes Mellitus. | Front Endocrinol (Lausanne) | 2022 |
| 35663309 | Serum miRNA Profile in Diabetic Patients With Ischemic Heart Disease as a Promising Non-Invasive Biomarker. | Front Endocrinol (Lausanne) | 2022 |
| 35690734 | Alpha-smooth muscle actin-positive cancer-associated fibroblasts secreting osteopontin promote growth of luminal breast cancer. | Cell Mol Biol Lett | 2022 |
| 35454913 | ERα36-High Cancer-Associated Fibroblasts as an Unfavorable Factor in Triple-Negative Breast Cancer. | Cancers (Basel) | 2022 |
| 35681658 | Expression Profile and Diagnostic Significance of MicroRNAs in Papillary Thyroid Cancer. | Cancers (Basel) | 2022 |
| 36557203 | Human Gut Microbiota in Coronary Artery Disease: A Systematic Review and Meta-Analysis. | Metabolites | 2022 |
| 36327219 | Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative. | PLoS Genet | 2022 |
| 36189248 | The short-term and long-term effects of intranasal mesenchymal stem cell administration to noninflamed mice lung. | Front Immunol | 2022 |
| 35163477 | The Role of Androgen Receptor and microRNA Interactions in Androgen-Dependent Diseases. | Int J Mol Sci | 2022 |
| 35088558 | Exploring microRNAs as predictive biomarkers for type 2 diabetes mellitus remission after sleeve gastrectomy: A pilot study. | Obesity (Silver Spring) | 2022 |
| 35205624 | MicroRNA Profile Alterations in Parathyroid Carcinoma: Latest Updates and Perspectives. | Cancers (Basel) | 2022 |
| 34314101 | Transcriptional profiling of paediatric ependymomas identifies prognostically significant groups. | J Pathol Clin Res | 2021 |
| 33808800 | Recent Highlights of Research on miRNAs as Early Potential Biomarkers for Cardiovascular Complications of Type 2 Diabetes Mellitus. | Int J Mol Sci | 2021 |
| 33658651 | Reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients. | Sci Rep | 2021 |
| 34768594 | Gut Microbiome in Chronic Coronary Syndrome Patients. | J Clin Med | 2021 |
| 34220949 | Aluminum or Low pH - Which Is the Bigger Enemy of Barley? Transcriptome Analysis of Barley Root Meristem Under Al and Low pH Stress. | Front Genet | 2021 |
| 32958038 | In search for interplay between stool microRNAs, microbiota and short chain fatty acids in Crohn's disease - a preliminary study. | BMC Gastroenterol | 2020 |
| 32093387 | Evaluation of Transcriptomic Regulations behind Metabolic Syndrome in Obese and Lean Subjects. | Int J Mol Sci | 2020 |
| 32664305 | Circulating miRNAs as a Predictive Biomarker of the Progression from Prediabetes to Diabetes: Outcomes of a 5-Year Prospective Observational Study. | J Clin Med | 2020 |
| 32911852 | Insulin Resistance and Endometrial Cancer: Emerging Role for microRNA. | Cancers (Basel) | 2020 |
| 32825530 | microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers is Mainly Dependent on HER2 Status-A Pilot Study. | Diagnostics (Basel) | 2020 |
| 32825120 | Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells. | Biomedicines | 2020 |
| 32650833 | Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes. | Acta Neuropathol Commun | 2020 |
| 31169260 | Efficacy of family history, genetic risk score, and physical activity in assessing the prevalence of type 2 diabetes. | Pol Arch Intern Med | 2019 |
| 31877723 | Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA). | Cancers (Basel) | 2019 |
| 31817685 | NF-kappa B Signaling-Related Signatures Are Connected with the Mesenchymal Phenotype of Circulating Tumor Cells in Non-Metastatic Breast Cancer. | Cancers (Basel) | 2019 |
| 31600929 | Sex-Specific Glucose Homeostasis and Anthropometric Responses to Sleeve Gastrectomy in Obese Patients. | Nutrients | 2019 |
| 31146417 | Novel Approaches in Ovarian Cancer Research against Heterogeneity, Late Diagnosis, Drug Resistance, and Transcoelomic Metastases. | Int J Mol Sci | 2019 |
| 30787377 | Prenatal circulating microRNA signatures of foetal Down syndrome. | Sci Rep | 2019 |
| 28579156 | The type 2 diabetes susceptibility TCF7L2 gene variants affect postprandial glucose and fat utilization in non-diabetic subjects. | Diabetes Metab | 2018 |
| 30094843 | Maternal plasma metabolic fingerprint indicative for fetal Down syndrome. | Prenat Diagn | 2018 |
| 29427151 | Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis. | J Neurooncol | 2018 |
| 28646744 | Systematic biobanking, novel imaging techniques, and advanced molecular analysis for precise tumor diagnosis and therapy: The Polish MOBIT project. | Adv Med Sci | 2017 |
| 28338501 | ALK Expression Is a Novel Marker for the WNT-activated Type of Pediatric Medulloblastoma and an Indicator of Good Prognosis for Patients. | Am J Surg Pathol | 2017 |
| 25601634 | The rs340874 PROX1 type 2 diabetes mellitus risk variant is associated with visceral fat accumulation and alterations in postprandial glucose and lipid metabolism. | Genes Nutr | 2015 |
| 24890801 | CYP3A4-dependent cellular response does not relate to CYP3A4-catalysed metabolites of C-1748 and C-1305 acridine antitumor agents in HepG2 cells. | Cell Biol Int | 2014 |
| 25175018 | Proteomics biomarkers for non-small cell lung cancer. | J Pharm Biomed Anal | 2014 |
| 23688499 | Pregnane X receptor dependent up-regulation of CYP2C9 and CYP3A4 in tumor cells by antitumor acridine agents, C-1748 and C-1305, selectively diminished under hypoxia. | Biochem Pharmacol | 2013 |
| 22484277 | Diminished toxicity of C-1748, 4-methyl-9-hydroxyethylamino-1-nitroacridine, compared with its demethyl analog, C-857, corresponds to its resistance to metabolism in HepG2 cells. | Biochem Pharmacol | 2012 |
| 21555506 | The imidazoacridinone antitumor drug, C-1311, is metabolized by flavin monooxygenases but not by cytochrome P450s. | Drug Metab Dispos | 2011 |
| 21859392 | Flavin monooxygenases, FMO1 and FMO3, not cytochrome P450 isoenzymes, contribute to metabolism of anti-tumour triazoloacridinone, C-1305, in liver microsomes and HepG2 cells. | Xenobiotica | 2011 |
| 19928584 | [Polymorphism and the level of P450 gene expression in xenobiotic metabolism]. | Postepy Biochem | 2009 |